---
type: "Symbol"
title: "MICROPORT EP (688351.SH) — Community Discussions"
description: "Community discussions about this stock, including analyst opinions, earnings analysis, and investment strategies from verified financial professionals and active investors."
locale: "en"
url: "https://longbridge.com/en/quote/688351.SH/topics.md"
symbol: "688351.SH"
parent: "https://longbridge.com/en/quote/688351.SH.md"
count: 1
datetime: "2026-03-13T11:52:27.932Z"
locales:
  - [en](https://longbridge.com/en/quote/688351.SH/topics.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/688351.SH/topics.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/688351.SH/topics.md)
---

# MICROPORT EP (688351.SH) — Community Discussions

### [科创板医药板块年度盘点：八成企业股价下跌，2 家企业市值超千亿](https://longbridge.com/en/topics/3950087.md)

- Author: [药械Talks](https://longbridge.com/en/profiles/6059509.md)
- Datetime: 2023-02-10T01:36:17.000Z
- Comments: 0
- 众所周知，科创板在医药类企业的融资中承担了重要的角色。自 2019 年 6 月开板以来，科创板市场已经迎来了上百家医药类企业上市融资，期间也造就了许多千亿市值企业。根据同花顺数据显示，截至 2022 年 12 月 30 日，科创板共有 102 家医药相关企业，其中有 23 家企业于 2022 年上市，主要涉及医疗器械、创新药及相关产业链。市值方面，2022 年有 6 家企业市值超过 300 亿元.

## References

- [MICROPORT EP (688351.SH)](https://longbridge.com/en/quote/688351.SH.md)


> Supported Languages: [简体中文](https://longbridge.com/zh-CN/quote/688351.SH/topics.md) | [繁體中文](https://longbridge.com/zh-HK/quote/688351.SH/topics.md)